Modifications of therapy

International Journal of Antimicrobial Agents

Volumn 16, Issue 2, 2000, Pages 139-141

  Kern, Winfried V ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Amphotenium B; Antifungal therapy; Empiric therapy; Febrile neutropenia

Indexed keywords

ACICLOVIR; AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ANTIVIRUS AGENT; FLUCONAZOLE; GLYCOPEPTIDE;

ARTICLE; DRUG CHOICE; FEBRILE NEUTROPENIA; FEVER; HUMAN; INFECTION; PRIORITY JOURNAL; RISK; SUPERINFECTION;

ANTI-INFECTIVE AGENTS; EMPIRICISM; FEVER; HUMAN; INFECTION; NEUTROPENIA;

EID: 0033780133     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(00)00219-3     Document Type: Article

References (10)

1. Duration of empiric antibiotic therapy in granulocytopenic patients with cancer
2. Short courses of antibiotics in selected febrile neutropenic patients
3. Early hospital discharge of children with cancer treated for fever and neutropenia: identification and management of the low-risk patient
4. Duration of intravenous antibiotics for patients with neutropenic fever
5. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever
6. Treatment of gram-positive septicemia in cancer patients
7. Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia
8. Empiric antifungal therapy in febrile granulocytopenic patients
9. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia